Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05512377
Title Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Boehringer Ingelheim
Age Groups: senior | adult
Covered Countries USA | GBR | FRA | ESP | DEU | BEL | AUT | AUS

Additional content available in CKB BOOST